787585-29-9

Usage

Uses

Used in Flavor and Fragrance Industry:
Methyl 2-(3-fluoro-4-Methylphenyl)acetate is used as a flavor or fragrance ingredient for its distinctive fruity, floral, and sweet aroma. It is incorporated into the production of perfumes, soaps, and other personal care products to enhance their scent profiles.
Used in Food Industry:
In the food industry, Methyl 2-(3-fluoro-4-Methylphenyl)acetate is used as a flavoring agent to add a unique taste and aroma to a variety of products such as beverages, candies, and baked goods, enhancing their overall sensory appeal.
Used in Pharmaceutical Industry:
Methyl 2-(3-fluoro-4-Methylphenyl)acetate also has potential applications in the pharmaceutical industry, where it serves as an intermediate in the synthesis of various drugs. Its chemical properties make it a valuable component in the development of new medicinal compounds.

Upstream product

• 67-56-1 methanol 
• 261951-74-0 2-(3-fluoro-4-methylphenyl)acetic acid 

Downstream Products

• 787585-30-2 1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-ol 

Relevant academic research and scientific papers

Enantioselective Construction of Quaternary All-Carbon Centers via Copper-Catalyzed Arylation of Tertiary Carbon-Centered Radicals

An enantioselective copper-catalyzed arylation of tertiary carbon-centered radicals, leading to quaternary all-carbon stereocenters, has been developed herein. The tertiary carbon-centered radicals, including both benzylic and nonbenzylic radicals, were produced by the addition of trifluoromethyl radical to α-substituted acrylamides, and subsequently captured by chiral aryl copper(II) species to give C-Ar bonds with excellent enantioselectivity. Importantly, an acylamidyl (CONHAr) group adjacent to the tertiary carbon radical is essential for the asymmetric radical coupling. The reaction itself features broad substrate scope, excellent functional group compatibility and mild conditions.

CaSR antagonist

A compound represented by the following formula (1), a pharmaceutically acceptable salt thereof or an optically active form thereof: wherein each symbol is as defined in the specification. A compound having a calcium-sensing receptor antagonistic action, a pharmaceutical composition comprising the compound, particularly a calcium receptor antagonist and a therapeutic drug for osteoporosis are provided.